Transplantation, HomologousHematopoietic Stem Cell TransplantationStem CellsGraft vs Host DiseaseBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation ConditioningStem Cell TransplantationHematopoietic Stem CellsHematologic NeoplasmsGraft SurvivalPlant StemsTransplantation ChimeraTransplantation, IsogeneicHematopoietic Stem Cell MobilizationAdult Stem CellsNeoplastic Stem CellsHistocompatibilityIsoantigensLymphocyte Culture Test, MixedLeukemiaTissue DonorsTreatment OutcomeGraft vs Tumor EffectPluripotent Stem CellsT-LymphocytesRecurrenceGranulocyte Colony-Stimulating FactorCombined Modality TherapyAntigens, CD34Leukemia, Myelogenous, Chronic, BCR-ABL PositiveWhole-Body IrradiationRemission InductionCyclophosphamideGraft vs Leukemia EffectNeural Stem CellsMelphalanStem Cell NicheMice, Inbred C57BLInduced Pluripotent Stem CellsAnemia, AplasticLeukemia, Myeloid, AcuteHistocompatibility TestingImmunosuppressionSkin TransplantationLymphoma, Non-HodgkinLeukapheresisTime FactorsBusulfanHematopoiesisMultipotent Stem CellsAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesGraft vs Host ReactionSurvival AnalysisMesenchymal Stromal CellsCells, CulturedLymphocyte ActivationBlood Component RemovalMice, Inbred BALB CTransplantation ImmunologyGraft RejectionMultiple MyelomaMesenchymal Stem Cell TransplantationNeoplasm, ResidualBone Marrow CellsCytotoxicity, ImmunologicLymphocyte DepletionStem Cell FactorSiblingsRadiation ChimeraSpleenMyeloablative AgonistsImmunosuppressive AgentsSurvival RateFlow CytometryBrain StemSalvage TherapyCarmustineEtoposideCytarabineVidarabineLeukocyte TransfusionDendritic CellsOpportunistic InfectionsCell SeparationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell ProliferationChimerismCell LineageInfectionCell DifferentiationImmune ToleranceBlood Transfusion, AutologousHLA AntigensMatched-Pair AnalysisAcute DiseaseMice, Inbred StrainsLymphocytes